Drug Discovery Services Market
Drug Discovery Services Market, By Product Type (Chemistry Services, Biology Services), By Therapeutic Area (Cardiovascular diseases, Digestive system diseases, Infectious and Immune system diseases), By Process (Target Selection, Target Validation, Hit-to-Lead identification), By End User (Academic Institutes, Pharmaceutical & Biotechnology companies - Forecast Year 2025 – 2032
Healthcare // Healthcare Analytics
The global drug
discovery services market is foreseen to grow by 12.5%, from USD 15.75 Billion
in 2021 to USD 40.41 Billion in 2029. Growing R&D expenditure in the pharma
& biopharma industry, high cost of in-house drug development, increasing
demand for outsourcing analytical testing is to drive the market for the
upcoming forecast period. However, stringent regulations governing drug
discovery and animal usage remains one factor hindering the market growth over
the anticipated period.
Market Definition
What is Drug Discovery Services?
Market Overview
The
drug discovery services market search study helps to thoroughly
understand the current trend in the market competitive analysis of the players
in the emerging market. Moreover, the DRO in the drug discovery services market
offers valuable perspicuity and a current scenario for making the right
decision. The research study covers the eminent players in the market with a
detailed analysis of the company and a financial overview containing their net
sales, business mix and geographical reach It mainly focuses on the key
developments of the products/services offered by the company in recent years.
Besides, we at Zettabyte have the expertise to analyses the global drug
discovery services market player's competitive landscape helping the client
comprehend their specific strategic growth approaches.
Drug discovery
services market study by "Zettabyte Analytics" offers details about
the market scope, market segmentation, technological advancement in the drug
discovery services market and highlights the optimistic, competitive landscape
and trends enduring over the years.
Major players in
the drug discovery services market include Aragen Life Sciences Pvt. Ltd.
(Formerly Gvk Biosciences Pvt. Ltd.), Charles River Laboratories International,
Inc., Curia Global Inc., Dalton Pharma Services, Domainex Ltd., Dr. Reddy’S
Laboratories Ltd. (Aurigene Discovery Technologies), Eurofins Scientific Se,
Evotec Se, Frontage Holdings Corporation, Genscript Biotech Corporation,
Jubilant Pharmova Limited, Laboratory Corporation Of America Holdings, Nuvisan
Pharma Holding Gmbh, Pharmaceutical Product Development, Inc., Pharmaron
Beijing Co., Ltd., Piramal Enterprises Limited, Promega Corporation, Selvita
S.A. (Formerly Selvita Cro S.A.), Shanghai Chempartner Co., Ltd., Shanghai
Medicilon Inc., Syngene International Limited, Tcg Lifesciences Pvt Ltd.,
Thermo Fisher Scientific, Viva Biotech (Shanghai) Ltd., Wuxi Apptec.
COVID-19 Impact on Global Drug
discovery services Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the drug discovery
services market has forced the companies to change their sourcing, pricing, and
promotion strategies. the drug discovery services market players are seen focusing
more on optimizing the e-commerce networks with the rising innovations in the
digital sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and drug discovery
services market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global drug discovery services market segmented on the
basis of product type, therapeutic area, process, end user, and region:
Product Type Outlook:
On the basis of
product type, the market is segmented into chemistry services, biology services.
Therapeutic Area Outlook:
On the basis of
therapeutic area, the market is segmented into cardiovascular diseases,
digestive system diseases, infectious and immune system diseases, neurology,
oncology, other therapeutic area.
Figure 1 Drug Discovery Services Market By Therapeutic
Area (Market Size And Forecast By Value - USD Million, 2021 & 2029)
Process Outlook:
On the basis of
process, the market is segmented into target selection, target validation,
hit-to-lead identification, lead optimization, candidate validation.
End Use Outlook:
On the basis of
end user, the market is segmented into academic institutes, pharmaceutical
& biotechnology companies, other end users.
Figure 2 End Use Outlook (Revenue, USD Million, 2021)
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 3 Drug Discovery Services Market:
Regional Dynamics
An exclusive drug
discovery services market research report provides an in-depth analysis of the
market dynamics across five regions: North America, Europe, South America,
Asia-Pacific, Middle East, and Africa. Furthermore, the market has been
evaluated by utilizing diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. some of the prominent players in the drug
discovery services market include
· Aragen Life
Sciences Pvt. Ltd. (Formerly Gvk Biosciences Pvt. Ltd.)
· Charles River
Laboratories International, Inc.
· Curia Global Inc.
· Dalton Pharma
Services
· Domainex Ltd.
· Dr. Reddy’S
Laboratories Ltd. (Aurigene Discovery Technologies)
· Eurofins Scientific
Se
· Evotec Se
· Frontage Holdings
Corporation
· Genscript Biotech
Corporation
· Jubilant Pharmova
Limited
· Laboratory
Corporation Of America Holdings
· Nuvisan Pharma
Holding Gmbh
· Pharmaceutical
Product Development, Inc.
· Pharmaron Beijing
Co., Ltd.
· Piramal Enterprises
Limited
· Promega Corporation
· Selvita S.A.
(Formerly Selvita Cro S.A.)
· Shanghai
Chempartner Co., Ltd.
· Shanghai Medicilon
Inc.
· Syngene
International Limited
· Tcg Lifesciences
Pvt Ltd.
· Thermo Fisher
Scientific
· Viva Biotech
(Shanghai) Ltd.
· Wuxi Apptec
Global Drug discovery services market Report
Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2029 |
USD 40.41 Billion |
|
Growth
Rate |
CAGR of 12.5%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product type, therapeutic area, process,
end user |
|
Key
companies profiled |
Laboratory
Corporation Of America Holdings, Charles River Laboratories International,
Inc., Wuxi Apptec |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Chemistry Services
· Biology Services
Therapeutic Area Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Cardiovascular
diseases
· Digestive system
diseases
· Infectious and
Immune system diseases
· Neurology
· Oncology
· Other Therapeutic
Area
Process Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Target Selection
· Target Validation
· Hit-to-Lead
identification
· Lead Optimization
· Candidate
Validation
End User Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Academic Institutes
· Pharmaceutical
& Biotechnology companies
· Other End Users
Regional Outlook (Revenue, USD
Million/Billion; 2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Reasons to Buy the Report:
· Save and reduce
time carrying out entry-level research by identifying the growth, size, leading
players and segments in the global drug discovery services market
· Highlights key
business priorities in order to guide the companies to reform their business
strategies and establish themselves in the wide geography.
· The key findings
and recommendations highlight crucial progressive industry trends in the drug
discovery services market, thereby allowing players to develop effective long-term
strategies in order to garner their market revenue.
· Develop/modify
business expansion plans by using substantial growth offering developed and
emerging markets.
· Scrutinize in-depth
global market trends and outlook coupled with the factors driving the market,
as well as those restraining the growth at a certain extent.
· Enhance the
decision-making process by understanding the strategies that underpin
commercial interest with respect to products, segmentation and industry
verticals.
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter 2. Executive
Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2018-2029 |
|
|
2.2. Drug Discovery Services Market
Share by Product Type, 2021 vs 2029 (USD Million) |
|
|
2.3. Drug Discovery Services Market
Share by Therapeutic Area, 2021 vs 2029 (USD Million) |
|
|
2.4. Drug Discovery Services Market
Share by Process, 2021 vs 2029 (USD Million) |
|
|
2.5. Drug Discovery Services Market
Share by End User, 2021 vs 2029 (USD Million) |
|
|
2.6. Drug Discovery Services Market
Share by Region, 2021 vs 2029 (USD Million) |
|
|
Chapter 3. Key Insights |
|
|
Chapter 4. Drug Discovery
Services Market Segmentation & Impact Analysis |
|
|
4.1. Drug Discovery Services Market
Indicators Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Growing
R&D expenditure in the pharma & biopharma industry |
|
|
4.1.1.2. High cost
of in-house drug development |
|
|
4.1.1.3. Increasing
demand for outsourcing analytical testing |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. Stringent
regulations governing drug discovery and animal usage |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Growth in
drugs and biologics market despite COVID-19 pandemic |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on Drug
Discovery Services Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.4. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter 6. Drug
Discovery Services Market, By Product Type (Market Size and Forecast by Value
- USD Million, 2018 - 2029) |
|
|
5.1. Drug Discovery Services Market, By
Product Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
|
5.1.1. Chemistry Services |
|
|
5.1.1.1. Chemistry Services Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
5.1.1.2. Chemistry Services Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.2. Biology Services |
|
|
5.1.2.1. Biology
Services Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.2.2. Biology Services
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 6. Drug
Discovery Services Market, By Therapeutic Area (Market Size and Forecast by
Value - USD Million, 2018 - 2029) |
|
|
6.1. Drug Discovery Services Market, By
Therapeutic Area (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
|
6.1.1. Cardiovascular diseases |
|
|
6.1.1.1. Cardiovascular diseases Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
6.1.1.2. Cardiovascular diseases Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.2. Digestive system
diseases |
|
|
6.1.2.1. Digestive system diseases Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.2. Digestive system diseases Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.3. Infectious and Immune
system diseases |
|
|
6.1.3.1. Infectious and
Immune system diseases Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.3.2. Infectious
and Immune system diseases Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.4. Neurology |
|
|
6.1.4.1. Neurology
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.2. Neurology
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5. Oncology |
|
|
6.1.5.1. Oncology Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.2. Oncology
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.6. Other Therapeutic Area |
|
|
6.1.6.1. Other Therapeutic
Area Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.6.2. Other
Therapeutic Area Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
Chapter 7. Drug
Discovery Services Market, By Process (Market Size and Forecast by Value -
USD Million, 2018 - 2029) |
|
|
7.1. Drug Discovery Services Market, By
Process (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
7.1.1. Target Selection |
|
|
7.1.1.1. Target Selection Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.1.2. Target Selection Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.2. Target Validation |
|
|
7.1.2.1. Target Validation Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.2.2. Target Validation Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.3. Hit-to-Lead
identification |
|
|
7.1.3.1. Hit-to-Lead
identification Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.3.2. Hit-to-Lead
identification Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.4. Lead Optimization |
|
|
7.1.4.1. Lead
Optimization Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.4.2. Lead Optimization Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.5. Candidate Validation |
|
|
7.1.5.1. Candidate Validation
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.5.2. Candidate
Validation Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 8. Drug
Discovery Services Market, By End User (Market Size and Forecast by Value -
USD Million, 2018 - 2029) |
|
|
8.1. Drug Discovery Services Market, By
End User (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
8.1.1. Academic Institutes |
|
|
8.1.1.1. Academic Institutes Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
8.1.1.2. Academic Institutes Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
8.1.2. Pharmaceutical & Biotechnology
companies |
|
|
8.1.2.1. Pharmaceutical & Biotechnology
companies Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.2.2. Pharmaceutical & Biotechnology
companies Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
8.1.3. Other End Users |
|
|
8.1.3.1. Other End
Users Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.3.2. Other End
Users Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 9. Drug Discovery
Services Market, By Region (Market Size and Forecast by Value - USD Million,
2018 - 2029) |
|
|
9.1. Drug Discovery Services Market, By
Region (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
9.2. North America |
|
|
9.2.1. North America Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.2. North America Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.2.3. North America Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.2.4. North America Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.2.5. North America Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
|
9.2.6. U.S. |
|
|
9.2.6.1. U.S.
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.6.2. U.S.
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.2.6.3. U.S. Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.2.6.4. U.S.
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.2.7. Canada |
|
|
9.2.7.1. Canada
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.7.2. Canada
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.2.7.3. Canada
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.2.7.4. Canada
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.3. Europe |
|
|
9.3.1. Europe Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.2. Europe Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.3.3. Europe Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.3.4. EuropeDrug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.3.5. Europe Drug Discovery
Services Market, By Country, 2018-2029 (USD Million) |
|
|
9.3.6. Germany |
|
|
9.3.6.1. Germany
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.6.2. Germany
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.3.6.3. Germany
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.3.6.4. Germany
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.3.7. U.K. |
|
|
9.3.7.1. U.K.
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.7.2. U.K.
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.3.7.3. U.K. Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.3.7.4. U.K.
Drug Discovery Services Market, By 10A, 2018-2029 (USD Million) |
|
|
9.3.8. France |
|
|
9.3.8.1. France Drug
Discovery Services Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.3.8.2. France Drug
Discovery Services Market, By Therapeutic Area, 2019-2029 (USD Million) |
|
|
9.3.8.3. France
Drug Discovery Services Market, By Process, 2019-2029 (USD Million) |
|
|
9.3.8.4. France
Drug Discovery Services Market, By End User, 2019-2029 (USD Million) |
|
|
9.3.9. Spain |
|
|
9.3.9.1. Spain
Drug Discovery Services Market, By Product Type, 2018-20210 (USD Million) |
|
|
9.3.9.2. Spain
Drug Discovery Services Market, By Therapeutic Area, 2018-20210 (USD Million) |
|
|
9.3.9.3. Spain
Drug Discovery Services Market, By Process, 2018-20210 (USD Million) |
|
|
9.3.9.4. Spain
Drug Discovery Services Market, By End User, 2018-20210 (USD Million) |
|
|
9.3.10. Italy |
|
|
9.3.10.1. Italy Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.10.2. Italy
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.3.10.3. Italy
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.3.10.4. Italy
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.3.11. Rest of Europe |
|
|
9.3.11.1. Rest of
Europe Drug Discovery Services Market, By Product Type, 2018-2029 (USD
Million) |
|
|
9.3.11.2. Rest of
Europe Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD
Million) |
|
|
9.3.9.3. Rest of
Europe Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.3.11.4. Rest of
Europe Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.4. Asia Pacific |
|
|
9.4.1. Asia Pacific Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.2. Asia Pacific Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.4.3. Asia Pacific Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.4.4. Asia Pacific Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.4.5. Asia Pacific Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
|
9.4.6. India |
|
|
9.4.6.1. India Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.6.2. India
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.4.6.3. India
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.4.6.4. India
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.4.7. Japan |
|
|
9.4.7.1. Japan
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.7.2. Japan
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.4.7.3. Japan
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.4.7.4. Japan
Drug Discovery Services Market, By 10A, 2018-2029 (USD Million) |
|
|
9.4.8. China |
|
|
9.4.8.1. China Drug
Discovery Services Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.4.8.2. China
Drug Discovery Services Market, By Therapeutic Area, 2019-2029 (USD Million) |
|
|
9.4.8.3. China
Drug Discovery Services Market, By Process, 2019-2029 (USD Million) |
|
|
9.4.8.4. China
Drug Discovery Services Market, By End User, 2019-2029 (USD Million) |
|
|
9.4.9. South Korea |
|
|
9.4.9.1. South
Korea Drug Discovery Services Market, By Product Type, 2018-20210 (USD
Million) |
|
|
9.4.9.2. South
Korea Drug Discovery Services Market, By Therapeutic Area, 2018-20210 (USD
Million) |
|
|
9.4.9.3. South
Korea Drug Discovery Services Market, By Process, 2018-20210 (USD Million) |
|
|
9.4.9.4. South
Korea Drug Discovery Services Market, By End User, 2018-20210 (USD Million) |
|
|
9.4.10. Australia |
|
|
9.4.10.1. Australia Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.10.2.
Australia Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD
Million) |
|
|
9.4.10.3. Australia Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.4.10.4.
Australia Drug Discovery Services Market, By End User, 2018-2029 (USD
Million) |
|
|
9.4.11. Rest of Asia Pacific |
|
|
9.4.11.1. Rest of
Asia Pacific Drug Discovery Services Market, By Product Type, 2018-2029 (USD
Million) |
|
|
9.4.11.2. Rest of
Asia Pacific Drug Discovery Services Market, By Therapeutic Area, 2018-2029
(USD Million) |
|
|
9.4.11.3. Rest of
Asia Pacific Drug Discovery Services Market, By Process, 2018-2029 (USD
Million) |
|
|
9.4.11.4. Rest of
Asia Pacific Drug Discovery Services Market, By End User, 2018-2029 (USD
Million) |
|
|
9.5. Middle East & Africa |
|
|
9.5.1. Middle East & Africa
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.5.2. Middle East & AfricaDrug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.5.3. Middle East & Africa
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.5.4. Middle East & Africa
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.5.5. Middle East & Africa
Drug Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
|
9.5.6. UAE |
|
|
9.5.6.1. UAE Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.5.6.2. UAE Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.5.6.3. UAE Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.5.6.4. UAE Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.5.7. Saudi Arabia |
|
|
9.5.7.1. Saudi
Arabia Drug Discovery Services Market, By Product Type, 2018-2029 (USD
Million) |
|
|
9.5.7.2. Saudi
Arabia Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD
Million) |
|
|
9.5.7.3. Saudi
Arabia Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.5.7.4. Saudi
Arabia Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.5.8. South Africa |
|
|
9.5.8.1. South
Africa Drug Discovery Services Market, By Product Type, 2019-20210 (USD
Million) |
|
|
9.5.8.2. South Africa
Drug Discovery Services Market, By Therapeutic Area, 2019-20210 (USD Million) |
|
|
9.5.8.3. South
Africa Drug Discovery Services Market, By Process, 2019-20210 (USD Million) |
|
|
9.5.8.4. South Africa Drug
Discovery Services Market, By End User, 2019-20210 (USD Million) |
|
|
9.5.9. Rest of Middle East
& Africa |
|
|
9.5.9.1. Rest of
Middle East & Africa Drug Discovery Services Market, By Product Type,
2018-20210 (USD Million) |
|
|
9.5.9.2. Rest of
Middle East & Africa Drug Discovery Services Market, By Therapeutic Area,
2018-20210 (USD Million) |
|
|
9.5.9.3. Rest of Middle East & Africa
Drug Discovery Services Market, By Process, 2018-20210 (USD Million) |
|
|
9.5.9.4. Rest of
Middle East & Africa Drug Discovery Services Market, By End User,
2018-20210 (USD Million) |
|
|
9.6. Latin America |
|
|
9.6.1. Latin America Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.2. Latin America Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.6.3. Latin America Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.6.4. Latin America Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.6.5. Latin America Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
|
9.6.6. Brazil |
|
|
9.6.6.1. Brazil
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.6.2. Brazil
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.6.6.3. Brazil
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.6.6.4. Brazil
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.6.7. Mexico |
|
|
9.6.7.1. Mexico
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.7.2. Mexico
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
|
9.6.7.3. Mexico
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
|
9.6.7.4. Mexico
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
|
9.6.8. Argentina |
|
|
9.6.8.1.
Argentina Drug Discovery Services Market, By Product Type, 2019-2029 (USD
Million) |
|
|
9.6.8.2.
Argentina Drug Discovery Services Market, By Therapeutic Area, 2019-2029 (USD
Million) |
|
|
9.6.8.3. Argentina
Drug Discovery Services Market, By Process, 2019-2029 (USD Million) |
|
|
9.6.8.4.
Argentina Drug Discovery Services Market, By End User, 2019-2029 (USD
Million) |
|
|
9.6.9. Rest of Latin America |
|
|
9.6.9.1. Rest of
Latin America Drug Discovery Services Market, By Product Type, 2018-20210
(USD Million) |
|
|
9.6.9.2. Rest of
Latin America Drug Discovery Services Market, By Therapeutic Area, 2018-20210
(USD Million) |
|
|
9.6.9.3. Rest of
Latin America Drug Discovery Services Market, By Process, 2018-20210 (USD
Million) |
|
|
9.6.9.4. Rest of
Latin America Drug Discovery Services Market, By End User, 2018-20210 (USD
Million) |
|
|
Chapter 10. Competitive Landscape |
|
|
10.1. Market Revenue Share by
Manufacturers |
|
|
10.2. Competitor’s Positioning |
|
|
10.3. Strategy Benchmarking |
|
|
10.3.1. Partnership &
Agreement |
|
|
10.3.2. New Product
Development |
|
|
10.3.3. Mergers &
Acquisitions |
|
|
10.3.4. Investment &
Expansion |
|
|
10.4. Vendor Landscape |
|
|
10.4.1. Distributors |
|
|
10.4.2. North America |
|
|
10.4.3. Europe |
|
|
10.4.4. Asia Pacific |
|
|
10.4.5. Middle East &
Africa |
|
|
10.4.6. Latin America |
|
|
10.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter 11. Company
Profiles |
|
|
11.1. Aragen Life Sciences Pvt. Ltd.
(Formerly Gvk Biosciences Pvt. Ltd.) |
|
|
11.1.1. Company Overview |
|
|
11.1.2. Products Offered |
|
|
11.1.3. Financials |
|
|
11.1.4. Recent
Development |
|
|
11.2. Charles River Laboratories
International, Inc. |
|
|
11.2.1. Company Overview |
|
|
11.2.2. Products Offered |
|
|
11.2.3. Financials |
|
|
11.2.4. Recent
Development |
|
|
11.3. Curia Global Inc. |
|
|
11.3.1. Company Overview |
|
|
11.3.2. Products Offered |
|
|
11.3.3. Financials |
|
|
11.3.4. Recent
Development |
|
|
11.4. Dalton Pharma Services |
|
|
11.4.1. Company Overview |
|
|
11.4.2. Products Offered |
|
|
11.4.3. Financials |
|
|
11.4.4. Recent
Development |
|
|
11.5. Domainex Ltd. |
|
|
11.5.1. Company Overview |
|
|
11.5.2. Products Offered |
|
|
11.5.3. Financials |
|
|
11.5.4. Recent
Development |
|
|
11.6. Dr. Reddy’S Laboratories Ltd.
(Aurigene Discovery Technologies) |
|
|
11.6.1. Company Overview |
|
|
11.6.2. Products Offered |
|
|
11.6.3. Financials |
|
|
11.6.4. Recent
Development |
|
|
11.7. Eurofins Scientific Se |
|
|
11.7.1. Company Overview |
|
|
11.7.2. Products Offered |
|
|
11.7.3. Financials |
|
|
11.7.4. Recent
Development |
|
|
11.8. Evotec Se |
|
|
11.8.1. Company Overview |
|
|
11.8.2. Products Offered |
|
|
11.8.3. Financials |
|
|
11.8.4. Recent
Development |
|
|
11.9. Frontage Holdings Corporation |
|
|
11.9.1. Company Overview |
|
|
11.9.2. Products Offered |
|
|
11.9.3. Financials |
|
|
11.9.4. Recent
Development |
|
|
11.10. Genscript Biotech Corporation |
|
|
11.10.1. Company Overview |
|
|
11.10.2. Products Offered |
|
|
11.10.3. Financials |
|
|
11.10.4. Recent
Development |
|
|
11.11. Jubilant Pharmova Limited |
|
|
11.11.1. Company Overview |
|
|
11.11.2. Products Offered |
|
|
11.11.3. Financials |
|
|
11.11.4. Recent
Development |
|
|
11.12. Laboratory Corporation Of America
Holdings |
|
|
11.12.1. Company Overview |
|
|
11.12.2. Products Offered |
|
|
11.12.3. Financials |
|
|
11.12.4. Recent
Development |
|
|
11.13. Nuvisan Pharma Holding Gmbh |
|
|
11.13.1. Company Overview |
|
|
11.13.2. Products Offered |
|
|
11.13.3. Financials |
|
|
11.13.4. Recent
Development |
|
|
11.14. Pharmaceutical Product
Development, Inc. |
|
|
11.14.1. Company Overview |
|
|
11.14.2. Products Offered |
|
|
11.14.3. Financials |
|
|
11.14.4. Recent
Development |
|
|
11.15. Pharmaron Beijing Co., Ltd. |
|
|
11.15.1. Company Overview |
|
|
11.15.2. Products Offered |
|
|
11.15.3. Financials |
|
|
11.15.4. Recent
Development |
|
|
11.16. Piramal Enterprises Limited |
|
|
11.16.1. Company Overview |
|
|
11.16.2. Products Offered |
|
|
11.16.3. Financials |
|
|
11.16.4. Recent
Development |
|
|
11.17. Promega Corporation |
|
|
11.17.1. Company Overview |
|
|
11.17.2. Products Offered |
|
|
11.17.3. Financials |
|
|
11.17.4. Recent
Development |
|
|
11.18. Selvita S.A. (Formerly Selvita
Cro S.A.) |
|
|
11.18.1. Company Overview |
|
|
11.18.2. Products Offered |
|
|
11.18.3. Financials |
|
|
11.18.4. Recent
Development |
|
|
11.19. Shanghai Chempartner Co., Ltd. |
|
|
11.19.1. Company Overview |
|
|
11.19.2. Products Offered |
|
|
11.19.3. Financials |
|
|
11.19.4. Recent
Development |
|
|
11.20. Shanghai Medicilon Inc. |
|
|
11.20.1. Company Overview |
|
|
11.20.2. Products Offered |
|
|
11.20.3. Financials |
|
|
11.20.4. Recent
Development |
|
|
11.21. Syngene International Limited |
|
|
11.21.1. Company Overview |
|
|
11.21.2. Products Offered |
|
|
11.21.3. Financials |
|
|
11.21.4. Recent
Development |
|
|
11.22. Tcg Lifesciences Pvt Ltd. |
|
|
11.22.1. Company Overview |
|
|
11.22.2. Products Offered |
|
|
11.22.3. Financials |
|
|
11.22.4. Recent
Development |
|
|
11.23. Thermo Fisher Scientific |
|
|
11.23.1. Company Overview |
|
|
11.23.2. Products Offered |
|
|
11.23.3. Financials |
|
|
11.23.4. Recent
Development |
|
|
11.24. Viva Biotech (Shanghai) Ltd. |
|
|
11.24.1. Company Overview |
|
|
11.24.2. Products Offered |
|
|
11.24.3. Financials |
|
|
11.24.4. Recent
Development |
|
|
11.25. Wuxi Apptec |
|
|
11.25.1. Company Overview |
|
|
11.25.2. Products Offered |
|
|
11.25.3. Financials |
|
|
11.25.4. Recent
Development |
|
|
Chapter 12. Research
Methodology |
|
|
12.1. Research Sources |
|
|
12.1.1. Primary |
|
|
12.1.2. Secondary |
|
|
12.12. Market Size Estimation |
|
|
Chapter 13. Appendix |
|
|
13.1. Discussion guide |
|
|
13.2. Knowledge Store:
Zettabyte Analytics Subscription Portal |
|
|
13.3. Available
Customizations |
|
|
13.4. Associated
Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
Table 1 |
Drug Discovery Services
Market, By Product Type (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
Table 2 |
Chemistry Services Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 3 |
Chemistry Services Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 4 |
Biology Services Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 5 |
Biology Services Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 6 |
Drug Discovery Services
Market, By Therapeutic Area (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
Table 7 |
Cardiovascular diseases
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 8 |
Cardiovascular diseases
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 9 |
Drug Discovery Services
Market, By Process (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Table 10 |
Target Selection Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 11 |
Target Selection Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 12 |
Target Validation Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 13 |
Target Validation Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 14 |
Drug Discovery Services
Market, By End User (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Table 15 |
Academic Institutes
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 16 |
Academic Institutes
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 17 |
Pharmaceutical &
Biotechnology companies Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
Table 18 |
Pharmaceutical &
Biotechnology companies Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
Table 19 |
North America Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 20 |
North America Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 21 |
North America Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 22 |
North America Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 23 |
North America Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
Table 24 |
U.S. Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 25 |
U.S. Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 26 |
U.S. Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 27 |
U.S. Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 28 |
Canada Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 29 |
Canada Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 30 |
Canada Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 31 |
Canada Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 32 |
Europe Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 33 |
Europe Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 34 |
Europe Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 35 |
EuropeDrug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 36 |
Europe Drug Discovery
Services Market, By Country, 2018-2029 (USD Million) |
|
Table 37 |
Germany Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 38 |
Germany Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 39 |
Germany Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 40 |
Germany Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 41 |
U.K. Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 42 |
U.K. Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 43 |
U.K. Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 44 |
U.K. Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 45 |
France Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 46 |
France Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 47 |
France Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 48 |
France Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 49 |
Spain Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 50 |
Spain Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 51 |
Spain Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 52 |
Spain Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 53 |
Italy Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 54 |
Italy Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 55 |
Italy Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 56 |
Italy Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 57 |
Rest of Europe Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 58 |
Rest of Europe Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 59 |
Rest of Europe Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 60 |
Rest of Europe Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 61 |
Asia Pacific Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 62 |
Asia Pacific Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 63 |
Asia Pacific Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 64 |
Asia Pacific Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 65 |
Asia Pacific Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
Table 66 |
India Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 67 |
India Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 68 |
India Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 69 |
India Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 70 |
Japan Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 71 |
Japan Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 72 |
Japan Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 73 |
Japan Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 74 |
China Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 75 |
China Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 76 |
China Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 77 |
China Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 78 |
South Korea Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 79 |
South Korea Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 80 |
South Korea Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 81 |
South Korea Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 82 |
Australia Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 83 |
Australia Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 84 |
Australia Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 85 |
Australia Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 86 |
Rest of Asia Pacific Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 87 |
Rest of Asia Pacific Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 88 |
Rest of Asia Pacific Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 89 |
Rest of Asia Pacific Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 90 |
Middle East & Africa
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 91 |
Middle East &
AfricaDrug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD
Million) |
|
Table 92 |
Middle East & Africa
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 93 |
Middle East & Africa
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 94 |
Middle East & Africa
Drug Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
Table 95 |
UAE Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 96 |
UAE Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 97 |
UAE Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 98 |
UAE Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 99 |
Saudi Arabia Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 100 |
Saudi Arabia Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 101 |
Saudi Arabia Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 102 |
Saudi Arabia Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 103 |
South Africa Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 104 |
South Africa Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 105 |
South Africa Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 106 |
South Africa Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 107 |
Rest of Middle East &
Africa Drug Discovery Services Market, By Product Type, 2018-2029 (USD
Million) |
|
Table 108 |
Rest of Middle East &
Africa Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD
Million) |
|
Table 109 |
Rest of Middle East &
Africa Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 110 |
Rest of Middle East &
Africa Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 111 |
Latin America Drug
Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 112 |
Latin America Drug
Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 113 |
Latin America Drug
Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 114 |
Latin America Drug
Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 115 |
Latin America Drug
Discovery Services Market, By Country, 2018-2029 (USD Million) |
|
Table 116 |
Brazil Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 117 |
Brazil Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 118 |
Brazil Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 119 |
Brazil Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 120 |
Mexico Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 121 |
Mexico Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 122 |
Mexico Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 123 |
Mexico Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 124 |
Argentina Drug Discovery
Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 125 |
Argentina Drug Discovery
Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 126 |
Argentina Drug Discovery
Services Market, By Process, 2018-2029 (USD Million) |
|
Table 127 |
Argentina Drug Discovery
Services Market, By End User, 2018-2029 (USD Million) |
|
Table 128 |
Rest of Latin America
Drug Discovery Services Market, By Product Type, 2018-2029 (USD Million) |
|
Table 129 |
Rest of Latin America
Drug Discovery Services Market, By Therapeutic Area, 2018-2029 (USD Million) |
|
Table 130 |
Rest of Latin America
Drug Discovery Services Market, By Process, 2018-2029 (USD Million) |
|
Table 131 |
Rest of Latin America
Drug Discovery Services Market, By End User, 2018-2029 (USD Million) |
|
Table 132 |
Product Launch & Development
in The Drug Discovery Services Market, 2018-2021 |
|
Table 133 |
Investment and Expansion
in The Drug Discovery Services Market, 2018-2021 |
|
Table 134 |
Partnership &
Collaboration in The Drug Discovery Services Market, 2018-2021 |
|
Table 135 |
Merger & Acquisition
in The Drug Discovery Services Market, 2018-2021 |
|
List of Figures |
|
|
Figure 1 |
Research Methodology |
|
Figure 2 |
Summary Snapshot Market
Size and Forecast, USD Million, 2021 & 2029 |
|
Figure 3 |
Global Drug Discovery
Services Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory Analysis |
|
Figure 5 |
COVID-19 Impact analysis
on Drug Discovery Services Market |
|
Figure 6 |
Market Revenue Share by
Manufacturers |
|
Figure 7 |
Drug Discovery Services
Market, By Product Type (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
Figure 8 |
Drug Discovery Services
Market, By Therapeutic Area (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
Figure 9 |
Drug Discovery Services
Market, By Process (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Figure 10 |
Drug Discovery Services
Market, By End User (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Figure 11 |
Drug Discovery Services
Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States